Anna Alonso-Saladrigues

7PUBLICATIONS
107CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cardiovascular medicine and haematology not elsewhere classifiedHaematologyHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Sep 30, 2026
Immunotherapy refractoriness and early post-alloHCT relapse define ultra-high-risk B-ALL after CD19 CAR T-cell therapy.

|Sep 30, 2026
BK Virus-Associated Hemorrhagic Cystitis in Nontransplanted Children With Hematological Malignancies: A Single-Center Case Series.

|Aug 31, 2026
Tisagenlecleucel for post-transplant relapse in young acute lymphoblastic leukemia patients: European real-world determinants of outcome.

|Apr 04, 2026
Impact of TP53 alterations on outcomes in pediatric and young adult patients with relapsed / refractory B-cell acute lymphoblastic leukemia after CD19-CAR T-Cell therapy.

Anna Alonso-Saladrigues, Elena Esperanza-Cebollada, Clara Vicente-Garcés

|Apr 07, 2025
Project EVOLVE: an international analysis of postimmunotherapy lineage switch, an emergent form of relapse in leukemia.

Sara K Silbert, Alexander W Rankin, Chloe N Hoang

|Sep 14, 2024
Use of Eltrombopag to Improve Thrombocytopenia and Tranfusion Requirement in Anti-CD19 CAR-T Cell-Treated Patients.

Maria-Eva Mingot-Castellano, Juan Luis Reguera-Ortega, Denis Zafra Torres

Pageof 2

Frequent Collaborators

6 joint publications

Susana Rives

3 joint publications

Antonio Perez-Martinez

2 joint publications

Sara Ghorashian

2 joint publications

Andishe Attarbaschi